Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-25-109298
Filing Date
2025-11-10
Accepted
2025-11-10 17:20:53
Documents
60
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q capr-20250930x10q.htm   iXBRL 10-Q 1857101
2 EX-31.1 capr-20250930xex31d1.htm EX-31.1 10474
3 EX-31.2 capr-20250930xex31d2.htm EX-31.2 10209
4 EX-32.1 capr-20250930xex32d1.htm EX-32.1 5740
5 EX-32.2 capr-20250930xex32d2.htm EX-32.2 5728
  Complete submission text file 0001104659-25-109298.txt   7278678

Data Files

Seq Description Document Type Size
6 EX-101.SCH capr-20250930.xsd EX-101.SCH 52061
7 EX-101.CAL capr-20250930_cal.xml EX-101.CAL 46924
8 EX-101.DEF capr-20250930_def.xml EX-101.DEF 200094
9 EX-101.LAB capr-20250930_lab.xml EX-101.LAB 407242
10 EX-101.PRE capr-20250930_pre.xml EX-101.PRE 330516
63 EXTRACTED XBRL INSTANCE DOCUMENT capr-20250930x10q_htm.xml XML 1169759
Mailing Address 10865 ROAD TO THE CURE SUITE 150 SAN DIEGO CA 92121
Business Address 10865 ROAD TO THE CURE SUITE 150 SAN DIEGO CA 92121 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34058 | Film No.: 251467442
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)